Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating dose-dense doxorubicin/cyclophosphamide with intermittent low-dose sunitinib in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Acupuncture and Breast Cancer Rehabilitation [NA]
A completed clinical trial from the Federal University of São Paulo evaluated acupuncture for pain management in breast cancer rehabilitatio…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC) [Phase 1]
Phase 1 imaging study using 111In-labeled pertuzumab to predict response to trastuzumab in HER2-positive breast cancer; the trial status is …
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating XL147 (SAR245408) in combination with trastuzumab or with paclitaxel and trastuzumab in meta…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer [Phase 1, Phase 2]
This document reports a completed Phase 1/2 clinical trial evaluating XL147 (SAR245408) or XL765 (SAR245409) in combination with letrozole f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer [NA]
The clinical trial evaluating whether flaxseed can prevent breast cancer in premenopausal women at risk has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer
A clinical trial evaluating eribulin (Halaven) for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Comparison of Diagnostic Accuracy of Automated Volume Breast Scanner to Hand Held Ultrasound for Diagnostic Breast Exam
This study compares the diagnostic accuracy of an automated volume breast scanner versus hand-held ultrasound for evaluating breast masses.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)
This clinical trial update reports a retrospective assessment of response to Faslodex (fulvestrant) 500 mg. The study involves patients with…
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: Epigenetic Testing for Breast Cancer Risk Stratification
The trial evaluated epigenetic testing to stratify breast cancer risk. The study is listed as completed.
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer [Phase 3]
Phase 3 trial comparing conventional versus hypofractionated radiotherapy in node-positive breast cancer; status currently unknown.
-
CLINICAL_TRIALS withdrawal · 2016-05-30Clinical Trial Update: A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer [NA]
A pilot preoperative trial of ganetespib with paclitaxel for triple-negative breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial update of bevacizumab with gemcitabine and carboplatin in participants with triple-negative metastatic breast cancer; results …
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor [Phase 2]
A Phase 2 randomized trial assessed fulvestrant with or without dasatinib in men and postmenopausal women with hormone receptor-positive adv…
-
CLINICAL_TRIALS research · 2016-05-25Clinical Trial Update: Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer [Phase 3]
Phase 3 trial exploring the prognostic value of changing endocrine therapy in women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update evaluating the PARP inhibitor rucaparib in BRCA1/BRCA2 mutation carriers with locally advanced or metastatic…
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Outpatient Clinic for Late Outcome for Breast Carcinoma in MAASTRO Clinic.
This trial result update describes a completed outpatient clinic study assessing late outcomes in breast cancer patients at the MAASTRO Clin…
-
CLINICAL_TRIALS research · 2016-05-24Clinical Trial Update: Limiting Chemotherapy Side Effects by Using Moxa [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating whether moxa (moxibustion) can limit chemotherapy-related side effects in patients with breast o…
-
CLINICAL_TRIALS research · 2016-05-24Clinical Trial Update: Risk Assessment Tool in Saudi Arabia
An ongoing clinical trial in Saudi Arabia sponsored by National Guard Health Affairs is evaluating a risk assessment tool for breast cancer.
-
CLINICAL_TRIALS research · 2016-05-24Clinical Trial Update: Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients [NA]
This document reports an ongoing clinical trial on neoadjuvant chemotherapy for operable premenopausal breast cancer, with status currently …
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy) [Phase 3]
This update notes the completion of a Phase 3 clinical trial comparing supine versus prone treatment positions in breast radiotherapy.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) [Phase 3]
Phase 3 PALOMA-3 trial evaluated palbociclib plus fulvestrant in HR+ HER2-negative metastatic breast cancer after endocrine failure; study c…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child [Phase 3]
Phase 3 clinical trial update about an intervention to help mothers with breast cancer support their children; the trial has completed.
-
CLINICAL_TRIALS research · 2016-05-20Clinical Trial Update: Histology of Functional Density in Premenopausal Breast
Completed Mayo Clinic clinical trial evaluating histology of functional density in premenopausal breast tissue.
-
FDA approval · 2016-05-19FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for FASLODEX (fulvestrant) from AstraZeneca Pharmaceuticals LP. This action updates the product …